Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
PeriWatch Surveillance represents a cutting-edge system for fetal monitoring and documentation, featuring the only automated maternal-fetal early warning system available commercially in the United States. This innovative solution provides near real-time analytical tools alongside adaptable workflows, aimed at enhancing the productivity and efficiency of labor and delivery teams while standardizing communication and facilitating informed decision-making. With its central surveillance and patient census capabilities, the system allows monitoring of up to 30 patients simultaneously on a single screen, effortlessly adjusting as patient counts fluctuate. The system also includes independent trending for each tracing and incorporates color-coded early warning notifications directly within its framework. Additionally, the patient census offers a detailed overview of all active patients, with customizable columns and color-coding that adheres to HIPAA regulations. Bedside monitoring is designed for user-friendliness, promoting seamless trending and easy access to documentation fields, featuring a natural progression of documentation screens tailored to clinical preferences. As a result, PeriWatch Surveillance not only improves patient outcomes but also enhances the overall workflow within healthcare settings.
Description
Scila has developed a sophisticated ecosystem of surveillance and risk management solutions tailored for various trading environments and asset classes, providing real-time analytics that can handle high volumes of data while maintaining a flexible architecture to adapt to ongoing regulatory and market shifts. Their leading products, Scila Surveillance and Scila Risk, effectively detect market abuse and suspicious activities across a wide range of assets, including equities, derivatives, FX, commodities, fixed income, and digital currencies, supported by customizable alert systems and data analytics that ensure a smooth transition from detection to evidence gathering. By transforming compliance into a strategic asset, Scila Surveillance allows for customized and nimble surveillance technology that scales in real-time, offers comprehensive coverage across multiple asset classes, utilizes AI for alert generation, and includes specialized workflows for investigation and case management. This innovative approach not only enhances compliance but also empowers firms to stay ahead in a rapidly evolving financial landscape.
API Access
Has API
No
API Access
Has API
No
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
Yes
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
No
Vendor Details
Company Name
PeriGen
Founded
1995
Country
United States
Website
perigen.com/Periwatch-Surveillance/
Vendor Details
Company Name
Scila
Founded
2008
Country
Sweden
Website
scila.se/
Product Features
Product Features
AML
Behavioral Analytics
No
Case Management
No
Compliance Reporting
No
Identity Verification
No
Investigation Management
No
PEP Screening
No
Risk Assessment
No
SARs
No
Transaction Monitoring
No
Watch List
No
Financial Risk Management
Compliance Management
No
Credit Risk Management
No
For Hedge Funds
No
Liquidity Analysis
No
Loan Portfolio Management
No
Market Risk Management
No
Operational Risk Management
No
Portfolio Management
No
Portfolio Modeling
No
Risk Analytics Benchmarks
No
Stress Tests
No
Value At Risk Calculation
No